Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALDORA
2024-516884-10-00Phase 3Completed
- Sponsor
- Strasbourg University Hospital
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Spironolactone with Placebo (2 arms). Primary endpoint: Proportion of patients achieving DAS28-CRP < 3.2. Started Sep 2024; status: completed.
02
Drugs
spironolactone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2024-516884-10-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516884-10-00.